51
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:February 28, 2023Completed
First in Human: 7278 Clinical Trials, Page 6 of 728
Hide Studies Not Open or Pending
52
First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System
Condition(s):Symptomatic Aortic StenosisLast Updated:February 4, 2019Completed
53
A First-in-human Study of the Safety, Tolerability, and PK of XFB-19 in Healthy Adult Volunteers
Condition(s):Idiopathic Pulmonary Fibrosis (IPF)Last Updated:July 19, 2022Not yet recruiting
54
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:February 8, 2023Not yet recruiting
55
A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies
Condition(s):B-cell Lymphoid MalignanciesLast Updated:August 10, 2022Not yet recruiting
56
First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers
Condition(s):Cholera; Cholera Vaccine ToxicityLast Updated:December 20, 2022Recruiting
57
Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder
Condition(s):Overactive BladderLast Updated:December 5, 2019Completed
58
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Condition(s):Advanced Malignant Neoplasm; Acute Myeloid Leukemia; Mixed Lineage Leukemia; Mixed Lineage Acute Leukemia; Acute Leukemia of Ambiguous Lineage; Mixed Phenotype Acute LeukemiaLast Updated:March 30, 2023Recruiting
59
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Condition(s):Locally Advanced Unresectable or Metastatic Solid TumorsLast Updated:November 14, 2022Recruiting
60
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Condition(s):Solid Tumor, Adult; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Non Hodgkin LymphomaLast Updated:November 7, 2022Recruiting